Found 8 matching trials
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer PHASE2 The goal of this clinical trial is to test if the addition of botensilimab ...
Show More Learn More & Join Trial
Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations PHASE2 In this study, the efficacy of botensilimab and balstilimab in mismatch rep...
Show More Location
The Netherlands Cancer Institute
Learn More & Join Trial
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases PHASE2 The goal of this clinical trial is to learn whether the combination of bals...
Show More Location
Scripps Clinic Torrey Pines
Learn More & Join Trial
Combination Immunotherapy in Colorectal Cancer PHASE2 This is a pilot study to see whether a combination of two investigational d...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital
Learn More & Join Trial
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval N/A This is an expanded access program (EAP) designed to provide access to Bote...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma PHASE2 Brain tumor treatment is hampered by the blood-brain barrier (BBB). This ba...
Show More Location
Northwestern University
Learn More & Join Trial
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial PHASE2 This phase II trial tests the effect of the botensilimab in combination wit...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease. PHASE2 Phase II, open label, randomized multicenter study to evaluate efficacy and...
Show More Location
Hospital Universitario Miguel Servet
Learn More & Join Trial